Titre : Collapsus ventriculaire

Collapsus ventriculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Brain Ischemia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Collapsus ventriculaire : Questions médicales les plus fréquentes", "headline": "Collapsus ventriculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Collapsus ventriculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-02", "dateModified": "2025-02-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Collapsus ventriculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Céphalée", "url": "https://questionsmedicales.fr/mesh/D006261", "about": { "@type": "MedicalCondition", "name": "Céphalée", "code": { "@type": "MedicalCode", "code": "D006261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.612.441" } } }, "about": { "@type": "MedicalCondition", "name": "Collapsus ventriculaire", "alternateName": "Slit Ventricle Syndrome", "code": { "@type": "MedicalCode", "code": "D056124", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexandr Malijevský", "url": "https://questionsmedicales.fr/author/Alexandr%20Malijevsk%C3%BD", "affiliation": { "@type": "Organization", "name": "Department of Physical Chemistry, University of Chemical Technology Prague, Prague 6, 166 28, Czech Republic and Czech Academy of Sciences, Institute of Chemical Process Fundamentals, Department of Molecular Modelling, 165 02 Prague, Czech Republic." } }, { "@type": "Person", "name": "Andrew O Parry", "url": "https://questionsmedicales.fr/author/Andrew%20O%20Parry", "affiliation": { "@type": "Organization", "name": "Department of Mathematics, Imperial College London, London SW7 2BZ, United Kingdom." } }, { "@type": "Person", "name": "Anna Maria Auricchio", "url": "https://questionsmedicales.fr/author/Anna%20Maria%20Auricchio", "affiliation": { "@type": "Organization", "name": "Institute of Neurosurgery, Catholic University of Rome." } }, { "@type": "Person", "name": "Marco Cenzato", "url": "https://questionsmedicales.fr/author/Marco%20Cenzato", "affiliation": { "@type": "Organization", "name": "Department of Neurosurgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy." } }, { "@type": "Person", "name": "Giuseppe Talamonti", "url": "https://questionsmedicales.fr/author/Giuseppe%20Talamonti", "affiliation": { "@type": "Organization", "name": "Department of Neurosurgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Generative adversarial network-created brain SPECTs of cerebral ischemia are indistinguishable to scans from real patients.", "datePublished": "2022-11-05", "url": "https://questionsmedicales.fr/article/36335166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23325-3" } }, { "@type": "ScholarlyArticle", "name": "Neural cortical organoids from self-assembling human iPSC as a model to investigate neurotoxicity in brain ischemia.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36655331", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0271678X231152023" } }, { "@type": "ScholarlyArticle", "name": "Pulsed Electromagnetic Fields Protect Against Brain Ischemia by Modulating the Astrocytic Cholinergic Anti-inflammatory Pathway.", "datePublished": "2022-07-13", "url": "https://questionsmedicales.fr/article/35831547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10571-022-01251-2" } }, { "@type": "ScholarlyArticle", "name": "Distribution of amyloid-β precursor protein-immunoreactive axons differs according to the severity of cerebral ischemia in autopsy brains.", "datePublished": "2022-05-09", "url": "https://questionsmedicales.fr/article/35534990", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/neup.12809" } }, { "@type": "ScholarlyArticle", "name": "LAMP-2A ablation in hippocampal CA1 astrocytes confers cerebroprotection and ameliorates neuronal injury after global brain ischemia.", "datePublished": "2022-09-04", "url": "https://questionsmedicales.fr/article/36059143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bpa.13114" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Céphalée", "item": "https://questionsmedicales.fr/mesh/D006261" }, { "@type": "ListItem", "position": 6, "name": "Collapsus ventriculaire", "item": "https://questionsmedicales.fr/mesh/D056124" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Collapsus ventriculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Collapsus ventriculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Collapsus ventriculaire", "description": "Comment diagnostique-t-on le syndrome du ventricule fendu ?\nQuels examens sont utilisés pour le diagnostic ?\nQuels symptômes indiquent un syndrome du ventricule fendu ?\nLe diagnostic nécessite-t-il une ponction lombaire ?\nPeut-on confondre ce syndrome avec d'autres conditions ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Collapsus ventriculaire", "description": "Quels sont les principaux symptômes du syndrome ?\nLes symptômes varient-ils selon les patients ?\nY a-t-il des signes d'urgence à surveiller ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?\nLe syndrome affecte-t-il la cognition ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Collapsus ventriculaire", "description": "Peut-on prévenir le syndrome du ventricule fendu ?\nQuelles mesures peuvent réduire les risques ?\nLes patients doivent-ils être éduqués sur les symptômes ?\nY a-t-il des recommandations pour les patients opérés ?\nLes contrôles réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Collapsus ventriculaire", "description": "Quel est le traitement principal du syndrome ?\nDes médicaments sont-ils utilisés pour traiter ce syndrome ?\nLa physiothérapie est-elle recommandée ?\nLe traitement est-il toujours chirurgical ?\nY a-t-il des traitements expérimentaux disponibles ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Collapsus ventriculaire", "description": "Quelles complications peuvent survenir ?\nLe syndrome peut-il entraîner des séquelles permanentes ?\nComment gérer les complications ?\nLes complications sont-elles fréquentes ?\nY a-t-il des risques de récidive ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Collapsus ventriculaire", "description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque de syndrome ?\nLes infections augmentent-elles le risque ?\nY a-t-il des prédispositions génétiques ?\nLe sexe influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D056124?mesh_terms=Brain+Ischemia&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le syndrome du ventricule fendu ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'imagerie cérébrale et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et le scanner sont couramment utilisés pour visualiser les ventricules cérébraux." } }, { "@type": "Question", "name": "Quels symptômes indiquent un syndrome du ventricule fendu ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des troubles neurologiques." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il une ponction lombaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une ponction lombaire peut être réalisée pour évaluer la pression du liquide céphalorachidien." } }, { "@type": "Question", "name": "Peut-on confondre ce syndrome avec d'autres conditions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec d'autres causes de maux de tête ou d'hydrocéphalie." } }, { "@type": "Question", "name": "Quels sont les principaux symptômes du syndrome ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux symptômes incluent des céphalées, des vomissements et des troubles de la vision." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les patients ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la gravité et de la durée de la condition." } }, { "@type": "Question", "name": "Y a-t-il des signes d'urgence à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une forte augmentation de la pression intracrânienne nécessitent une attention immédiate." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver et mener à des complications graves." } }, { "@type": "Question", "name": "Le syndrome affecte-t-il la cognition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de la pression sur le cerveau." } }, { "@type": "Question", "name": "Peut-on prévenir le syndrome du ventricule fendu ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un suivi régulier des patients avec dérivation peut aider." } }, { "@type": "Question", "name": "Quelles mesures peuvent réduire les risques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un contrôle régulier de la pression intracrânienne et une gestion adéquate des dérivations sont essentiels." } }, { "@type": "Question", "name": "Les patients doivent-ils être éduqués sur les symptômes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation des patients sur les symptômes est cruciale pour une détection précoce." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les patients opérés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les patients doivent suivre les recommandations post-opératoires pour éviter les complications." } }, { "@type": "Question", "name": "Les contrôles réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers sont nécessaires pour surveiller l'état du patient après une dérivation." } }, { "@type": "Question", "name": "Quel est le traitement principal du syndrome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la révision de la dérivation ou la mise en place d'une nouvelle dérivation." } }, { "@type": "Question", "name": "Des médicaments sont-ils utilisés pour traiter ce syndrome ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et des médicaments pour réduire la pression intracrânienne peuvent être prescrits." } }, { "@type": "Question", "name": "La physiothérapie est-elle recommandée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie peut être bénéfique pour améliorer la fonction neurologique après traitement." } }, { "@type": "Question", "name": "Le traitement est-il toujours chirurgical ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, des options non chirurgicales peuvent être envisagées selon la gravité." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux peuvent être en cours, mais leur efficacité n'est pas encore prouvée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'hydrocéphalie, les infections et les troubles neurologiques." } }, { "@type": "Question", "name": "Le syndrome peut-il entraîner des séquelles permanentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles neurologiques permanentes peuvent survenir si le traitement est retardé." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite souvent une intervention chirurgicale ou un ajustement du traitement." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont relativement rares mais peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de récidive du syndrome est possible, nécessitant une surveillance continue." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de chirurgie cérébrale et les dérivations mal positionnées augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de syndrome ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les adultes jeunes sont plus susceptibles de développer ce syndrome." } }, { "@type": "Question", "name": "Les infections augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent augmenter le risque de complications liées aux dérivations." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des prédispositions génétiques peuvent exister, mais elles ne sont pas encore bien comprises." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que le sexe peut influencer le risque, mais les résultats sont variables." } } ] } ] }

Sources (10000 au total)

Pulsed Electromagnetic Fields Protect Against Brain Ischemia by Modulating the Astrocytic Cholinergic Anti-inflammatory Pathway.

Neuroinflammation is one of the most important pathological processes following brain ischemia. Pulsed electromagnetic fields (PEMFs) protect against brain ischemia, but their role in regulating neuro...

Activated neutrophil-derived exosomes contribute to blood-brain barrier damage and hemorrhagic transformation after cerebral ischemia/reperfusion.

Hemorrhagic transformation (HT) caused by blood-brain barrier (BBB) damage is closely correlated with the poor prognosis of ischemic stroke. Neutrophils are proven to mediate BBB injury after ischemic... A tMCAO-HT model was constructed to assess neutrophil infiltration and its co-localization with brain microvascular endothelial cells (BMEC). After using quiet (Q-Neu) and activated neutrophil (A-Neu)... Different degrees of cerebral hemorrhage were observed in the tMCAO-HT model. The expression of the neutrophil marker Ly6G was significantly increased in tMCAO-HT model compared to the sham group, and... Neutrophils are abnormally recruited in HT after ischemic stroke, and are associated with cerebral hemorrhage. In vitro, A-Neu-derived exosomes facilitate BBB injury, which may be accomplished by exos...

Brain-targeted heptapeptide-loaded exosomes attenuated ischemia-reperfusion injury by promoting the transfer of healthy mitochondria from astrocytes to neurons.

The exchange of mitochondria reportedly plays an important role in cell-cell communication in the central nervous system (CNS). The transfer of fragmented and dysfunctional astrocytic mitochondria int... In this study, we prepared macrophage-derived exosomes laden with heptapeptide (Hep) as a dynamin-related protein-1 (Drp1)-fission 1 (Fis1) peptide inhibitor P110 to alleviate cerebral ischemia-reperf... The results demonstrated that Hep-loaded macrophage-derived exosomes (EXO-Hep) reduced mitochondrial damage in astrocytes by inhibiting the Drp1/Fis1 interaction after ischemia-reperfusion, ensuring t... EXO-Hep significantly mitigated ischemic injury in a model of transient middle cerebral artery occlusion (tMCAO) by reducing the infarct area and improving neurological performance during the process ...

Whole-brain CT Perfusion at Admission and During Delayed Time-window Detects the Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage.

To evaluate the utility of computed tomography perfusion (CTP) both at admission and during delayed cerebral ischemia time-window (DCITW) in the detection of delayed cerebral ischemia (DCI) and the ch... Eighty patients underwent CTP at admission and during DCITW. The mean and extreme values of all CTP parameters at admission and during DCITW were compared between the DCI group and non-DCI group, and ... With the exception of cerebral blood volume (P=0.295, admission; P=0.682, DCITW), there were significant differences in the mean quantitative CTP parameters between DCI and non-DCI patients both at ad... Whole-brain CTP can predict the occurrence of DCI at admission and diagnose DCI during DCITW. The extreme quantitative parameters and qualitative color-coded perfusion maps can better reflect the perf...

Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

After subarachnoid hemorrhage (SAH), early brain injury (EBI) and delayed cerebral ischemia (DCI) lead to poor outcomes. Discovery of biomarkers indicative of disease severity and predictive of DCI is... We performed untargeted proteomics using mass spectrometry in plasma samples collected at < 48 h of SAH in two independent discovery cohorts (n = 27 and n = 45) and identified LRG1 as a biomarker for ... Untargeted proteomics revealed higher plasma LRG1 levels across EBI severity and DCI in both discovery cohorts. In the validation cohort, the levels of LRG1 were higher in the DCI group compared with ... Plasma LRG1 is a biomarker for EBI, DCI, and functional outcomes after SAH. Further studies to elucidate the role of LRG1 in the pathophysiology of SAH are needed....